Olive Branch Health Secures Hundreds of Millions in Back-to-Back Series A+ and A++ Funding to Advance Primary Healthcare Digitization

VCBeat (WeChat ID: vcbeat) has learned that Olive Branch Health, a digital service provider for primary healthcare, has announced the consecutive completion of its Series A+ and Series A++ financing rounds, totaling hundreds of millions of yuan.

The Series A+ round was led by Sherpa Capital, and the Series A++ round was led by Matrix Partners China. Existing shareholders IDG Capital and Jiacheng Capital continued to support both rounds. The funds raised will be used for market expansion, supplementing R&D and operational capital, and continuously attracting top talent.

Olive Branch Health, founded in 2017, initially entered the market with health appointment services. It has since evolved to offer preventive medicine services, including vaccination, health screenings, and diagnostic testing. By integrating a suite of digital tools and operational services, the company empowers primary healthcare settings, helping to strengthen health education, improve efficiency, and expand service offerings and accessibility.

Primary healthcare centers are standalone medical institutions serving the permanent residents within their jurisdictions, undertaking basic public health service functions that encompass extensive prevention, health management, and health education initiatives. Unlike clinical and pharmaceutical services, health management and prevention require more proactive educational and interventional services; for instance, adult vaccination necessitates enhanced awareness campaigns and improved cognitive understanding. To this end, Olive Branch Health not only applies digital solutions but also places greater emphasis on digital operations in primary care settings.

Aligning with the national digital economy strategy and leveraging market demands and opportunities in primary healthcare and public health, we are driving the deep integration of digitalization and the health economy. This facilitates the rapid flow of resource elements and empowers the upgrading of the digital industry for primary healthcare. Capitalizing on the digital consensus within the industry, Olive Branch Health has established strategic partnerships with multiple upstream and downstream institutions. For instance, during the China International Import Expo (CIIE), a strategic partnership was announced with Sanofi Pasteur to jointly explore and build a digital ecosystem for vaccines. Focusing on enhancing public awareness and acceptance of vaccines, and supporting the improvement of digital service capabilities within the public health system, we are jointly advancing the implementation of a new service ecosystem for vaccines—from education to vaccination. This aims to increase vaccine coverage rates and improve the convenience of vaccination.

Scenario-based digital transformation also encompasses the integration of hardware services. Olive Branch has participated in the research and development of smart unmanned vaccination pods, which systematically integrate vaccination services through cloud-based registration, intelligent pre-screening, and automated administration, thereby enhancing efficiency and user experience.

The Olive Branch Health team stated: Following this round of financing, the company will continue to adhere to the strategic guidance of "Healthy China" and "Prevention First," align with the national digital economy strategy, and strive to become a digital practitioner in health and preventive services in China by digitizing the operations of primary healthcare. It will focus on laying out its presence in preventive medicine fields such as vaccines, health screenings, and diagnostic testing. With primary healthcare service scenarios at the core, digitalization as the tool, and smart operations aimed at promoting public health, the company is committed to continuously improving the accessibility of health services and striving to build the first line of defense for public health.